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Herpes zoster is a benign and usually self-limiting disease,
although herpes zoster has a notorious reputation among lay peo-
ple because of the acute pain during an attack1 and because of the
common myth that herpes zoster located circumferentially on the
trunk is fatal. We report an unusual case of bilateral symmetric her-
pes zoster on the trunk.
A 57-year-old woman presented with intermittent shooting
pain (with a visual analog scale of 8) on the low back for 2 days.
She went to an orthopedic outpatient department where a lumbar
X-ray image revealed no abnormal ﬁndings. Muscle sprain or psy-
chogenic pain was suspected. Five days later, she came to our
dermatology department where grouped vesicles on erythematous
bases were present bilaterally along the T10 dermatome on both
sides (Figure 1). Severe pain led to sleep disturbance at night and
lethargy in the daytime. There were no other associated systemic
symptoms.
She was diagnosed as having herpes zoster duplex bilateralis
symmetricus (HZDBS). She had a medical history of hypertension,
hyperlipidemia, and depression. She was otherwise healthy and
was not taking any systemic immunosuppressive agents or cortico-
steroids. Laboratory examinations were all within normal range
and included complete blood cell counts with differential counts,
liver and renal function tests, electrolyte levels, urine analysis,
and tumor markers. Serology for human immunodeﬁciency virus
(HIV) was negative. We prescribed analgesics and local soothing
agents. The skin lesions subsided uneventfully in 1 week; however,
mild pain persisted.
Herpes zoster is a common skin disease caused by a reactivation
of varicella zoster virus infection in the dorsal root ganglion of the
sensory nerves. Herpes zoster usually resolves spontaneously;
however, it signiﬁcantly impairs a person's quality of life during
an acute attack.1 In addition, it may be complicated by postherpetic
neuralgia, zoster encephalomyelitis, disseminated herpes zoster,
etc. Herpes zoster usually involves only one dermatome; it is espe-
cially common on the chest wall.2
Herpes zoster occurring in two noncontiguous, widely sepa-
rated dermatomes has been referred to as zoster duplex unilater-
alis or zoster duplex bilateralis, depending on whether it involves
one-half of the body or both halves of the body, respectively.
However, HZDBS does not need to have the same degree of
severity of both sides; it only requires that the lesions occur at
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than 0.5%.3 The incidence of HZDBS is even rarer and some der-
matologists consider it nonexistent. Based on our literature
search, there are only four additional reported cases of HZDBS
(Table 1).4e7 In these four cases, two cases occurred in immuno-
compromised patients, and all rashes were distributed on the
thoracic dermatomes. In another report,8 herpes zoster recurred
1.5 years later on the contralateral side of the same dermatome
(the left T8 dermatome and then the right T8 dermatome) in a
HIV-infected patient.
Herpes zoster virus reactivations are associated with a decline
in cell-mediated immunity. However, the presence of an immu-
nocompromised status in patients with HZDBS seems less com-
mon, compared to patients with recurrent herpes zoster (HZ)
or nonsymmetric herpes zoster duplex bilateralis. One-half of
HZDBS patients, including our patient, have a relatively normal
immunity, which suggests a different mechanism exists between
HZDBS and recurrent HZ. In addition, the disease course of
HZDBS is similar to the course of common HZ with skin lesions
healing in 7e10 days. There are no reports of severe skin necro-
sis, recurrences, or evolution into cutaneous or visceral dissemi-
nation (Table 1).
Herpes zoster most commonly affects the thoracic dermatomes.
The reason that all reported cases of HZDBS occur on thoracic der-
matomes may be related to the limited reported number of cases.
Another possibility is that the distance is shorter between two
thoracic ganglions than between the cervical and lumbosacral
ganglia, which facilitates the local transmission of the HZ virus
from one sensory ganglion to the contralateral side, as Shin et al5
suggest. Other published cases of herpes zoster duplex bilateralis
without symmetric distribution are not conﬁned to thoracic
dermatomes.
One pitfall in the diagnosis of HZDBS in our patient is the lack
of viral isolation, pathology, or Tzanck smear to further conﬁrm
the diagnosis. However, herpes zoster is usually diagnosed clini-
cally. Our patient showed a typical clinical presentation of group-
ed zosteriform vesicles and subsequent crust formation. Her
clinical course was also compatible with prodromal pain and
with pain persisting after the skin lesions healed. Another possi-
bility for bilateral zosteriform vesicles is zosteriform herpes sim-
plex. However, bilateral symmetric dermatomal herpes simplex
has not been reported in the literature, the pain in herpes simplex
usually subsides immediately after the skin lesions heal, and a
history of multiple recurrences at the same site was not present
in our patient.
We have described an unusual case of HZDBS in a nonimmuno-
compromised patient. The exact incidence and mechanism behind
this unique phenomenon await further studies.ier Taiwan LLC. All rights reserved.
Figure 1 (A, B) Symmetric grouped vesicles on an erythematous base occur red simultaneously on the low back. (C) Close-up view of the left lesion. (D) Close-up view of the right
lesion.
Table 1 The reported cases of herpes zoster duplex bilateralis symmetricus.
Cited papers Immunocompromised disease Age (y) Sex Site (dermatome) Disease duration Treatment
Shin et al4 (J Dermatol 2009) Ulcerative colitis treated with
prednisolone for 7 months
21 M T9eT10 Not mentioned i.v. Antiviral agent
Yoo et al5 (Cancer Res Treat 2009) Breast cancer stage II status
post chemotherapy 4 y ago
49 F T4 Not mentioned Famciclovir 750 mg per
day for 7 days
Arfan-ul-Bari et al6
(J Coll Physicians Surg Pak 2003)
Nil NA M Lower chest NA NA
Agrawal et al7 (Int J Dermatol 2014) Nil 50 F T3eT4 Resolved completely
within 2 weeks
Acyclovir 800 mg 5
times a day for 10 days
Tsai et al (the present case) Nil 57 F T10 Subsided in 1 week Analgesics
F ¼ female; i.v. ¼ intravenous; M ¼ male; NA ¼ not available.
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